• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模型化持续肾脏替代治疗中的纵向血液透析滤过性能。

Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.

机构信息

Department of Clinical, Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, Mich., USA.

出版信息

Blood Purif. 2011;32(2):82-8. doi: 10.1159/000324191. Epub 2011 Mar 2.

DOI:10.1159/000324191
PMID:21372565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3064935/
Abstract

BACKGROUND/AIMS: With advanced anticoagulation, many institutions operate continuous renal replacement therapy (CRRT) circuits longer than manufacturers' recommendations. This extended use may change hemodiafilter performance and clearance properties. However, hemodiafilter performance over time has not been assessed. We investigated solute clearance over time in modeled CRRT.

METHODS

In vitro continuous hemofiltration (CH) and continuous hemodialysis (CD) were operated for 48 h using AN69 polyacrylonitrile, cellulose triacetate, F70 polysulfone, and Optiflux F160NR polysulfone hemodiafilters with citrated bovine blood. Urea, creatinine, gentamicin, vancomycin, and albumin clearances were assessed in CH (ultrafiltration rates = 1 and 3 l/h). Clearances of urea, creatinine, gentamicin, and albumin, were assessed in CD with dialysate flow rate of 2 l/h.

RESULTS

Solute CH clearances were significantly higher at 3 l/h. Only creatinine and gentamicin clearances were affected by time. Creatinine CD clearance significantly declined at 48 h for all hemodiafilters, especially polysulfone hemodiafilters.

CONCLUSIONS

CRRT duration affects solute transmembrane clearance. Clinicians should consider hemodiafilter age when assessing hemodialysis dose or drug clearance.

摘要

背景/目的:随着先进的抗凝治疗,许多机构使用连续肾脏替代疗法(CRRT)的时间超过了制造商的建议。这种延长的使用可能会改变血液透析滤过器的性能和清除特性。然而,血液透析滤过器的性能随时间的推移尚未得到评估。我们研究了模型化 CRRT 中溶质清除随时间的变化。

方法

使用含柠檬酸的牛血在体外连续血液滤过(CH)和连续血液透析(CD)中运行 48 小时,使用 AN69 聚丙烯腈、纤维素三醋酸酯、F70 聚砜和 Optiflux F160NR 聚砜血液透析滤过器。在 CH 中评估了尿素、肌酐、庆大霉素、万古霉素和白蛋白的清除率(超滤率为 1 和 3 l/h)。在 CD 中,以 2 l/h 的透析液流速评估了尿素、肌酐、庆大霉素和白蛋白的清除率。

结果

3 l/h 时溶质 CH 清除率显著升高。只有肌酐和庆大霉素的清除率受时间影响。所有血液透析滤过器的肌酐 CD 清除率在 48 小时时显著下降,尤其是聚砜血液透析滤过器。

结论

CRRT 持续时间会影响溶质跨膜清除率。临床医生在评估血液透析剂量或药物清除率时应考虑血液透析滤过器的年龄。

相似文献

1
Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.模型化持续肾脏替代治疗中的纵向血液透析滤过性能。
Blood Purif. 2011;32(2):82-8. doi: 10.1159/000324191. Epub 2011 Mar 2.
2
Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.持续肾脏替代治疗期间替拉万星与羟丙基-β-环糊精的清除率:一项体外研究。
Int J Artif Organs. 2009 Oct;32(10):745-51. doi: 10.1177/039139880903201006.
3
Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy.体外持续肾脏替代治疗期间替加环素的吸附及跨膜清除率
Blood Purif. 2015;40(1):66-71. doi: 10.1159/000430904. Epub 2015 Jun 27.
4
Ertapenem clearance during modeled continuous renal replacement therapy.在模拟的连续性肾脏替代治疗期间厄他培南的清除率。
Int J Artif Organs. 2008 Dec;31(12):1027-34. doi: 10.1177/039139880803101206.
5
Daptomycin clearance during modeled continuous renal replacement therapy.模拟持续肾脏替代治疗期间达托霉素的清除率。
Blood Purif. 2006;24(5-6):548-54. doi: 10.1159/000097078. Epub 2006 Nov 16.
6
Iohexol transmembrane clearance during modeled continuous renal replacement therapy.
Blood Purif. 2015;39(1-3):188-192. doi: 10.1159/000371755.
7
Acetaminophen clearance during ex vivo continuous renal replacement therapies.对乙酰氨基酚在离体持续肾脏替代治疗期间的清除情况。
J Artif Organs. 2018 Jun;21(2):215-219. doi: 10.1007/s10047-017-1001-6. Epub 2017 Oct 23.
8
Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.低透析液流速下小溶质的透析器清除率和传质面积系数。
ASAIO J. 2006 Jul-Aug;52(4):404-9. doi: 10.1097/01.mat.0000227687.88929.08.
9
Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.在模拟持续肾脏替代治疗期间甲氧苄啶和磺胺甲恶唑的跨膜清除率
Blood Purif. 2014;38(3-4):195-202. doi: 10.1159/000368884. Epub 2014 Dec 16.
10
Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results.新型荧光示踪剂 MB-102 在连续肾脏替代治疗中的吸附和清除:体外研究结果。
ASAIO J. 2023 Jul 1;69(7):702-707. doi: 10.1097/MAT.0000000000001943. Epub 2023 Jun 27.

引用本文的文献

1
Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future Directions.儿科体外治疗中的药代动力学研究:现状与未来方向。
Blood Purif. 2024 Jun;53(6):520-526. doi: 10.1159/000534828. Epub 2024 Feb 28.
2
"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study.“CATCH”研究:危重症患者连续性肾脏替代治疗中持续血液滤过的正确抗生素治疗:一项前瞻性观察性研究
Antibiotics (Basel). 2022 Dec 13;11(12):1811. doi: 10.3390/antibiotics11121811.
3
Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review.急性肾衰竭危重症患者的抗生素治疗与肾脏替代治疗:一篇叙述性综述
Antibiotics (Basel). 2022 Dec 7;11(12):1769. doi: 10.3390/antibiotics11121769.
4
A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy.《连续性肾脏替代治疗中镇痛药、抗惊厥药和精神药物给药的临床医生指南》
Kidney Int Rep. 2021 May 13;6(8):2033-2048. doi: 10.1016/j.ekir.2021.05.004. eCollection 2021 Aug.
5
Reply to Baud and Houzé, "Should and Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?".对博德和胡泽的回复:“连续性肾脏替代治疗期间抗菌药物的研究是否应遵循药代动力学的一般原则?”
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00401-20.
6
A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.《危重症合并肾脏替代治疗患者抗菌药物剂量调整指南》
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00583-19. Print 2019 Aug.
7
A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding.一种采用局部枸橼酸抗凝的 CVVH 模式与急性肾损伤且高出血风险患者不抗凝治疗的比较。
Sci Rep. 2019 Apr 29;9(1):6607. doi: 10.1038/s41598-019-42916-1.
8
Renal replacement therapy: a practical update.肾脏替代治疗:实用更新。
Can J Anaesth. 2019 May;66(5):593-604. doi: 10.1007/s12630-019-01306-x. Epub 2019 Feb 6.
9
Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study.接受持续肾脏替代治疗的重症患者废水中亚胺培南治疗药物监测的临床验证:一项初步研究。
PLoS One. 2016 Apr 19;11(4):e0153927. doi: 10.1371/journal.pone.0153927. eCollection 2016.

本文引用的文献

1
Ertapenem clearance during modeled continuous renal replacement therapy.在模拟的连续性肾脏替代治疗期间厄他培南的清除率。
Int J Artif Organs. 2008 Dec;31(12):1027-34. doi: 10.1177/039139880803101206.
2
The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters.万古霉素在聚丙烯腈、聚酰胺和聚砜血液滤过器上的吸附作用。
Artif Organs. 2008 Jan;32(1):81-4. doi: 10.1111/j.1525-1594.2007.00460.x.
3
Adsorption of amikacin, a significant mechanism of elimination by hemofiltration.阿米卡星的吸附作用,这是血液滤过清除药物的一个重要机制。
Antimicrob Agents Chemother. 2008 Mar;52(3):1009-13. doi: 10.1128/AAC.00858-07. Epub 2007 Dec 17.
4
Drug dosing in continuous renal replacement therapy: general rules.连续性肾脏替代治疗中的药物剂量:一般规则。
Curr Opin Crit Care. 2007 Dec;13(6):645-51. doi: 10.1097/MCC.0b013e3282f0a3d3.
5
Trace element removal during in vitro and in vivo continuous haemodialysis.体外和体内连续血液透析过程中微量元素的去除
Nephrol Dial Transplant. 2007 Oct;22(10):2970-7. doi: 10.1093/ndt/gfm352. Epub 2007 Jun 7.
6
Daptomycin clearance during modeled continuous renal replacement therapy.模拟持续肾脏替代治疗期间达托霉素的清除率。
Blood Purif. 2006;24(5-6):548-54. doi: 10.1159/000097078. Epub 2006 Nov 16.
7
Current status of dosing and quantification of acute renal replacement therapy. Part 2: dosing paradigms and clinical implementation.急性肾替代治疗的剂量与定量现状。第2部分:剂量模式与临床应用
Nephrology (Carlton). 2006 Jun;11(3):181-91. doi: 10.1111/j.1440-1797.2006.00581.x.
8
The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration an in vitro study of levofloxacin.吸附、滤材及稀释点对血液滤过清除抗生素的影响:左氧氟沙星的体外研究
Int J Antimicrob Agents. 2004 Nov;24(5):468-72. doi: 10.1016/j.ijantimicag.2004.06.005.
9
Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.使用局部枸橼酸盐抗凝改善持续性肾脏替代治疗的实施效果。
Clin Nephrol. 2004 Feb;61(2):134-43. doi: 10.5414/cnp61134.
10
Higher renal replacement therapy dose delivery influences on drug therapy.更高的肾脏替代治疗剂量输送对药物治疗的影响。
Artif Organs. 2003 Sep;27(9):808-14. doi: 10.1046/j.1525-1594.2003.07283.x.